Levy Bruno, Bastien Olivier, Karim Bendjelid, Cariou Alain, Chouihed Tahar, Combes Alain, Mebazaa Alexandre, Megarbane Bruno, Plaisance Patrick, Ouattara Alexandre, Spaulding Christian, Teboul Jean-Louis, Vanhuyse Fabrice, Boulain Thierry, Kuteifan Kaldoun
CHU Nancy, Service de Réanimation Médicale Brabois; Pôle Cardiovasculaire et Réanimation Médicale, Hopital Brabois, 54511, Vandoeuvre-les-Nancy, France,
Ann Intensive Care. 2015 Dec;5(1):52. doi: 10.1186/s13613-015-0052-1. Epub 2015 Jul 1.
Unlike for septic shock, there are no specific international recommendations regarding the management of cardiogenic shock (CS) in critically ill patients. We present herein recommendations for the management of cardiogenic shock in adults, developed with the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system by an expert group of the French-Language Society of Intensive Care (Société de Réanimation de Langue Française (SRLF)), with the participation the French Society of Anesthesia and Intensive Care (SFAR), the French Cardiology Society (SFC), the French Emergency Medicine Society (SFMU), and the French Society of Thoracic and Cardiovascular Surgery (SFCTCV). The recommendations cover 15 fields of application such as: epidemiology, myocardial infarction, monitoring, vasoactive drugs, prehospital care, cardiac arrest, mechanical assistance, general treatments, cardiac surgery, poisoning, cardiogenic shock complicating end-stage cardiac failure, post-shock treatment, various etiologies, and medical care pathway. The experts highlight the fact that CS is a rare disease, the management of which requires a multidisciplinary technical platform as well as specialized and experienced medical teams. In particular, each expert center must be able to provide, at the same site, skills in a variety of disciplines, including medical and interventional cardiology, anesthesia, thoracic and vascular surgery, intensive care, cardiac assistance, radiology including for interventional vascular procedures, and a circulatory support mobile unit.
与感染性休克不同,目前尚无关于危重症患者心源性休克(CS)管理的具体国际建议。在此,我们展示由法语重症监护学会(Société de Réanimation de Langue Française (SRLF))的一个专家小组,在法国麻醉与重症监护学会(SFAR)、法国心脏病学会(SFC)、法国急诊医学学会(SFMU)以及法国胸心血管外科学会(SFCTCV)的参与下,采用推荐分级评估、制定与评价(GRADE)系统制定的成人心源性休克管理建议。这些建议涵盖15个应用领域,如:流行病学、心肌梗死、监测、血管活性药物、院前护理、心脏骤停、机械辅助、一般治疗、心脏手术、中毒、终末期心力衰竭并发的心源性休克、休克后治疗、各种病因以及医疗护理途径。专家们强调,心源性休克是一种罕见疾病,其管理需要多学科技术平台以及专业且经验丰富的医疗团队。特别是,每个专家中心必须能够在同一地点提供多种学科的技能,包括内科和介入心脏病学、麻醉、胸外科和血管外科、重症监护、心脏辅助、包括介入血管手术在内的放射学,以及一个循环支持移动单元。